Black cohosh — The Menopausal Modulator
Black cohosh is a botanical extract traditionally used to alleviate menopausal symptoms such as hot flashes and mood disturbances. While it lacks direct evidence for extending lifespan, its ability to modulate neurotransmitter pathways may improve healthspan and quality of life during the menopausal transition.
Mechanism of Action
The exact mechanism of action of black cohosh remains incompletely understood, but it is no longer considered a classic phytoestrogen. Instead of binding directly to estrogen receptors, evidence suggests it acts as a mixed competitive ligand and partial agonist at serotonin receptors (e.g., 5-HT1A and 5-HT7). It may also modulate dopaminergic, GABAergic, and mu-opioid pathways, which could explain its effects on thermoregulation and mood during menopause. Its direct relevance to core longevity pathways like mTOR or AMPK is poorly characterised.
Human Trial Evidence
No published human longevity trials. Animal/in-vitro evidence only. Clinical trials in humans have primarily focused on its efficacy for alleviating menopausal symptoms, such as hot flashes and mood disturbances, with mixed results.
Dosing Protocol
20–40 mg of standardized extract (e.g., Remifemin) taken once or twice daily is the most studied range in humans. It is typically used for up to 6 months. If dose-finding for longevity is unestablished in humans, say so: Dose-finding for longevity is unestablished in humans.
Safety & Contraindications
Generally well-tolerated for short-term use (up to 6 months), with mild side effects like gastrointestinal upset or rash. However, there are rare but severe case reports of hepatotoxicity and acute liver failure associated with its use. It is contraindicated in individuals with a history of liver disease or those taking hepatotoxic drugs. Its safety in hormone-sensitive cancers (e.g., breast cancer) remains controversial, and it should be avoided in these populations.